Therapeutic targeting of EPH receptors and their ligands
- PMID: 24378802
- DOI: 10.1038/nrd4175
Therapeutic targeting of EPH receptors and their ligands
Abstract
Critical roles for EPH receptor (EPH)-ephrin signalling in a range of chronic and regenerative diseases are increasingly being recognized. In particular, the complex roles of EPHs and ephrins in tumour growth and progression, and in nerve injury and regeneration have been studied extensively. This has led to considerable progress in developing strategies for their therapeutic targeting, with some anticancer agents already in clinical trials. Promising leads for non-malignant diseases are also emerging, with compelling preclinical data encouraging clinical development. We discuss this rapidly developing area of drug discovery, highlighting the associated challenges and limitations.
Similar articles
-
Eph receptors and ephrins: therapeutic opportunities.Annu Rev Pharmacol Toxicol. 2015;55:465-87. doi: 10.1146/annurev-pharmtox-011112-140226. Epub 2014 Oct 3. Annu Rev Pharmacol Toxicol. 2015. PMID: 25292427 Free PMC article. Review.
-
Eph receptors and ephrins.Int J Biochem Cell Biol. 2003 Feb;35(2):130-4. doi: 10.1016/s1357-2725(02)00096-1. Int J Biochem Cell Biol. 2003. PMID: 12479863 Review.
-
Eph receptors and ephrins in cancer progression.Nat Rev Cancer. 2024 Jan;24(1):5-27. doi: 10.1038/s41568-023-00634-x. Epub 2023 Nov 23. Nat Rev Cancer. 2024. PMID: 37996538 Free PMC article. Review.
-
Ephrins and Eph receptors in stem cells and cancer.Curr Opin Cell Biol. 2010 Oct;22(5):611-6. doi: 10.1016/j.ceb.2010.08.005. Curr Opin Cell Biol. 2010. PMID: 20810264 Review.
-
Functions of ephrin/Eph interactions in the development of the nervous system: emphasis on the hippocampal system.Brain Res Brain Res Rev. 2005 Sep;49(2):211-26. doi: 10.1016/j.brainresrev.2005.02.001. Epub 2005 Mar 29. Brain Res Brain Res Rev. 2005. PMID: 16111551 Review.
Cited by
-
HIF1α-AS1 is a DNA:DNA:RNA triplex-forming lncRNA interacting with the HUSH complex.Nat Commun. 2022 Nov 2;13(1):6563. doi: 10.1038/s41467-022-34252-2. Nat Commun. 2022. PMID: 36323673 Free PMC article.
-
EphA2- and HDAC-Targeted Combination Therapy in Endometrial Cancer.Int J Mol Sci. 2024 Jan 20;25(2):1278. doi: 10.3390/ijms25021278. Int J Mol Sci. 2024. PMID: 38279277 Free PMC article.
-
EphrinB2 expression in prostate adenocarcinoma: Implications for targeted therapy.Pathol Res Pract. 2020 Jun;216(6):152967. doi: 10.1016/j.prp.2020.152967. Epub 2020 Apr 19. Pathol Res Pract. 2020. PMID: 32362422 Free PMC article.
-
Juxtacrine Signaling Inhibits Antitumor Immunity by Upregulating PD-L1 Expression.Cancer Res. 2018 Jul 15;78(14):3761-3768. doi: 10.1158/0008-5472.CAN-18-0040. Epub 2018 May 22. Cancer Res. 2018. PMID: 29789418 Free PMC article.
-
Mutational analysis of genes coding for cell surface proteins in colorectal cancer cell lines reveal novel altered pathways, druggable mutations and mutated epitopes for targeted therapy.Oncotarget. 2014 Oct 15;5(19):9199-213. doi: 10.18632/oncotarget.2374. Oncotarget. 2014. PMID: 25193853 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous